Pain Relief after Hip Replacement Surgery: A comparison of two approaches

Optimising Pain Relief after Hip Replacement Surgery: A comparison of Patient Controlled Lumbar Plexus Block and Patient Controlled Iintravenous (IV) Opioid Analgesia

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12609000316202

Enrollment

Registered

2009-05-21

Start date

2009-05-23

Completion date

2013-04-09

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

If the primary hypothesis is confirmed, this study will provide evidence supporting the Patient Controlled Lumbar Plexus Block for postoperative analgesia for total hip replacement surgery. Increased exposure of the techniques may promote their uptake in this setting.

Interventions

Patient controlled continuous lumbar plexus block (ropivacaine 0.2% 5 ml/hr with as required 5 ml boluses via a catheter inserted near the lumbar plexus) during the first 48 postoperative hours after hip replacement surgery

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Treatment

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Patients requiring analgesia following hip replacement surgery under the care of the three investigators

Exclusion criteria

1. Patient refusal of either block. 2. Known neuropathy involving the leg undergoing surgery. 3. Known allergy to amide local anaesthetic drugs.

Outcome results